EP 3817756 A2 20210512 - BCL-2 ANTIBODIES AND IMMUNOASSAY FOR DIAGNOSIS OF CANCER
Title (en)
BCL-2 ANTIBODIES AND IMMUNOASSAY FOR DIAGNOSIS OF CANCER
Title (de)
BCL-2-ANTIKÖRPER UND IMMUNOASSAY ZUR KREBSDIAGNOSE
Title (fr)
ANTICORPS ANTI-BCL-2 ET DOSAGE IMMUNOLOGIQUE POUR LE DIAGNOSTIC DU CANCER
Publication
Application
Priority
- US 201862694142 P 20180705
- US 2019040683 W 20190705
Abstract (en)
[origin: WO2020010304A2] The present invention is directed to a monoclonal antibody that recognizes human BCL-2 in its native form. The invention is also directed to a hybridoma cell line that produces the monoclonal antibody, and to immunoassays such as ELISA and Lateral flow Assay tests for quantifying the quantity of BCL-2 for diagnosing cancer.
IPC 8 full level
A61K 38/00 (2006.01); A61K 39/395 (2006.01); A61K 45/00 (2006.01)
CPC (source: EP)
C07K 14/4747 (2013.01); C07K 16/28 (2013.01); G01N 33/57488 (2013.01); G01N 2333/4703 (2013.01)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2020010304 A2 20200109; WO 2020010304 A3 20200312; CA 3105726 A1 20200109; EP 3817756 A2 20210512; EP 3817756 A4 20220330; JP 2021530247 A 20211111
DOCDB simple family (application)
US 2019040683 W 20190705; CA 3105726 A 20190705; EP 19830072 A 20190705; JP 2021521944 A 20190705